[{"id":"50678700-d055-4cef-b1a1-d47e586162a0","acronym":"","url":"https://clinicaltrials.gov/study/NCT05683418","created_at":"2023-01-13T15:59:27.234Z","updated_at":"2024-07-02T16:34:36.935Z","phase":"Phase 1","brief_title":"A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors","source_id_and_acronym":"NCT05683418","lead_sponsor":"Totus Medicines","biomarkers":" HER-2 • PIK3CA","pipe":" | ","alterations":" HER-2 negative • PIK3CA mutation","tags":["HER-2 • PIK3CA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative • PIK3CA mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TOS-358"],"overall_status":"Recruiting","enrollment":" Enrollment 241","initiation":"Initiation: 02/15/2023","start_date":" 02/15/2023","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2024-06-10"}]